-
1Academic Journal
المؤلفون: Sonia Jaramillo (11646087), Johannes Krisam (3710305), Lucian Le Cornet (11646090), Markus Kratzmann (11646093), Lukas Baumann (9713420), Tim Sauer (3204375), Martina Crysandt (3547991), Andreas Rank (6058313), Dirk Behringer (11646096), Lino Teichmann (11646099), Martin Görner (771783), Ralf-Ulrich Trappe (11646102), Christoph Röllig (106766), Stefan Krause (473710), Maher Hanoun (175319), Olaf Hopfer (66495), Gerhard Held (422792), Sebastian Buske (11646105), Lars Fransecky (276595), Sabine Kayser (11646108), Christoph Schliemann (719713), Kerstin Schaefer-Eckart (10029410), Yousef Al-Fareh (11646111), Jörg Schubert (4780), Thomas Geer (11646114), Martin Kaufmann (2069674), Arne Brecht (6636905), Dirk Niemann (11646117), Meinhard Kieser (19173), Martin Bornhäuser (219605), Uwe Platzbecker (3175935), Hubert Serve (106786), Claudia D. Baldus (11646120), Carsten Müller-Tidow (105305), Richard F. Schlenk (2736112)
مصطلحات موضوعية: Medicine, Pharmacology, Immunology, Cancer, Science Policy, Hematology, gemtuzumab ozogamicin, glasdegib, acute myeloid leukemia, measurable residual disease
-
2Academic Journal
المؤلفون: Sonia Jaramillo (11646087), Johannes Krisam (3710305), Lucian Le Cornet (11646090), Markus Kratzmann (11646093), Lukas Baumann (9713420), Tim Sauer (3204375), Martina Crysandt (3547991), Andreas Rank (6058313), Dirk Behringer (11646096), Lino Teichmann (11646099), Martin Görner (771783), Ralf-Ulrich Trappe (11646102), Christoph Röllig (106766), Stefan Krause (473710), Maher Hanoun (175319), Olaf Hopfer (66495), Gerhard Held (422792), Sebastian Buske (11646105), Lars Fransecky (276595), Sabine Kayser (11646108), Christoph Schliemann (719713), Kerstin Schaefer-Eckart (10029410), Yousef Al-Fareh (11646111), Jörg Schubert (4780), Thomas Geer (11646114), Martin Kaufmann (2069674), Arne Brecht (6636905), Dirk Niemann (11646117), Meinhard Kieser (19173), Martin Bornhäuser (219605), Uwe Platzbecker (3175935), Hubert Serve (106786), Claudia D. Baldus (11646120), Carsten Müller-Tidow (105305), Richard F. Schlenk (2736112)
مصطلحات موضوعية: Medicine, Pharmacology, Immunology, Cancer, Science Policy, Hematology, gemtuzumab ozogamicin, glasdegib, acute myeloid leukemia, measurable residual disease
-
3
المؤلفون: Olle Holmberg (11333088), Tobias Lenz (3316332), Valentin Koch (11833181), Aseel Alyagoob (11833184), Léa Utsch (11833187), Andreas Rank (6058313), Emina Sabic (11833190), Masaru Seguchi (8763498), Erion Xhepa (8307723), Sebastian Kufner (8307720), Salvatore Cassese (8307717), Adnan Kastrati (95640), Carsten Marr (173699), Michael Joner (4318597), Philipp Nicol (11833199)
-
4Image
المؤلفون: Olle Holmberg (11333088), Tobias Lenz (3316332), Valentin Koch (11833181), Aseel Alyagoob (11833184), Léa Utsch (11833187), Andreas Rank (6058313), Emina Sabic (11833190), Masaru Seguchi (8763498), Erion Xhepa (8307723), Sebastian Kufner (8307720), Salvatore Cassese (8307717), Adnan Kastrati (95640), Carsten Marr (173699), Michael Joner (4318597), Philipp Nicol (11833199)
-
5Image
المؤلفون: Olle Holmberg (11333088), Tobias Lenz (3316332), Valentin Koch (11833181), Aseel Alyagoob (11833184), Léa Utsch (11833187), Andreas Rank (6058313), Emina Sabic (11833190), Masaru Seguchi (8763498), Erion Xhepa (8307723), Sebastian Kufner (8307720), Salvatore Cassese (8307717), Adnan Kastrati (95640), Carsten Marr (173699), Michael Joner (4318597), Philipp Nicol (11833199)